Literature DB >> 26030047

Financial burden after allogeneic hematopoietic cell transplantation: a qualitative analysis from the patient's perspective.

W Kim1, J McNulty1, Y-H Chang2, M Weise3, S Hashmi4, S Ailawadhi5, N Khera3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26030047     DOI： 10.1038/bmt.2015.128

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  Reporting and grading financial toxicity.

Authors:  Nandita Khera
Journal:  J Clin Oncol       Date:  2014-09-08       Impact factor: 44.544

2.  Financial burden in recipients of allogeneic hematopoietic cell transplantation.

Authors:  Nandita Khera; Yu-hui Chang; Shahrukh Hashmi; James Slack; Timothy Beebe; Vivek Roy; Pierre Noel; Veena Fauble; Lisa Sproat; Jon Tilburt; Jose F Leis; Joseph Mikhael
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-24       Impact factor: 5.742

3.  Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation.

Authors:  Jada G Hamilton; Lisa M Wu; Jane E Austin; Heiddis Valdimarsdottir; Katie Basmajian; Annamarie Vu; Scott D Rowley; Luis Isola; William H Redd; Christine Rini
Journal:  Psychooncology       Date:  2012-05-18       Impact factor: 3.894

4.  The quality of health insurance service delivery for kidney transplant recipients: a patient perspective.

Authors:  E J Gordon; D Conti
Journal:  Am J Transplant       Date:  2010-10       Impact factor: 8.086

5.  Self-reported financial burden and satisfaction with care among patients with cancer.

Authors:  Fumiko Chino; Jeffrey Peppercorn; Donald H Taylor; Ying Lu; Gregory Samsa; Amy P Abernethy; S Yousuf Zafar
Journal:  Oncologist       Date:  2014-03-25

6.  Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.

Authors:  Reshma Jagsi; John A E Pottow; Kent A Griffith; Cathy Bradley; Ann S Hamilton; John Graff; Steven J Katz; Sarah T Hawley
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

7.  Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; T Hahn; S J Lee; P L McCarthy; M Ammi; E Denzen; R Drexler; S Flesch; H James; N Omondi; T L Pedersen; E Murphy; K Pederson
Journal:  Bone Marrow Transplant       Date:  2012-12-10       Impact factor: 5.483

8.  Medical costs and productivity losses of cancer survivors--United States, 2008-2011.

Authors:  Donatus U Ekwueme; K Robin Yabroff; Gery P Guy; Matthew P Banegas; Janet S de Moor; Chunyu Li; Xuesong Han; Zhiyuan Zheng; Anita Soni; Amy Davidoff; Ruth Rechis; Katherine S Virgo
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-06-13       Impact factor: 17.586
  8 in total
  14 in total

1.  Costs of hematopoietic stem cell transplantation in a developing country.

Authors:  Monica M Rivera-Franco; Eucario Leon-Rodriguez; Haydee L Castro-Saldaña
Journal:  Int J Hematol       Date:  2017-06-14       Impact factor: 2.490

2.  Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation.

Authors:  Linda J Burns; Beatrice Abbetti; Stacie D Arnold; Jeffrey Bender; Susan Doughtie; Areej El-Jawahiri; Gloria Gee; Theresa Hahn; Mary M Horowitz; Shirley Johnson; Mark Juckett; Lakshmanan Krishnamurit; Susan Kullberg; C Fred LeMaistre; Alison Loren; Navneet S Majhail; Elizabeth A Murphy; Doug Rizzo; Alva Roche-Green; Wael Saber; Barry A Schatz; Kim Schmit-Pokorny; Bronwen E Shaw; Karen L Syrjala; D Kathryn Tierney; Christina Ullrich; David J Vanness; William A Wood; Ellen M Denzen
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-03       Impact factor: 5.742

Review 3.  Palliative care during and following allogeneic hematopoietic stem cell transplantation.

Authors:  Sandra A Mitchell
Journal:  Curr Opin Support Palliat Care       Date:  2018-03       Impact factor: 2.302

Review 4.  Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

Authors:  Minoo Battiwalla; André Tichelli; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-03       Impact factor: 5.742

5.  The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia.

Authors:  G Gifford; N Gilroy; G Dyer; L Brice; M Kabir; M Greenwood; S Larsen; J Moore; D Gottlieb; M Hertzberg; J Kwan; G Huang; J Tan; L Brown; M Hogg; C Ward; I Kerridge
Journal:  Bone Marrow Transplant       Date:  2016-05-23       Impact factor: 5.483

6.  Late effects of blood and marrow transplantation.

Authors:  Rahul Banerjee; Marlise R Luskin; Alison W Loren
Journal:  Haematologica       Date:  2017-11       Impact factor: 9.941

Review 7.  Financial Hardship--an Unwanted Consequence of Cancer Treatment.

Authors:  Julie McNulty; Nandita Khera
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

Review 8.  National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.

Authors:  Shahrukh K Hashmi; Christopher Bredeson; Rafael F Duarte; Stephanie Farnia; Susan Ferrey; Courtney Fitzhugh; Mary E D Flowers; James Gajewski; Dennis Gastineau; Melissa Greenwald; Madan Jagasia; Patricia Martin; J Douglas Rizzo; Kimberly Schmit-Pokorny; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-03       Impact factor: 5.742

9.  Cost of HSCT in a Tertiary Care Public Sector Hospital in India.

Authors:  Vinay Goel; Pankaj Arora; Pankaj Malhotra; Anil Kumar Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2021-03-08       Impact factor: 0.900

Review 10.  Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant.

Authors:  Anna Barata; William A Wood; Sung Won Choi; Heather S L Jim
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.